Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
15.64
+0.21 (1.39%)
May 5, 2025, 4:00 PM EDT - Market closed

Mineralys Therapeutics Statistics

Total Valuation

MLYS has a market cap or net worth of $1.01 billion. The enterprise value is $815.83 million.

Market Cap 1.01B
Enterprise Value 815.83M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, before market open.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

MLYS has 64.88 million shares outstanding. The number of shares has increased by 34.13% in one year.

Current Share Class 64.88M
Shares Outstanding 64.88M
Shares Change (YoY) +34.13%
Shares Change (QoQ) +0.29%
Owned by Insiders (%) 1.89%
Owned by Institutions (%) 54.96%
Float 42.92M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.07
P/TBV Ratio 5.30
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.02

Current Ratio 14.02
Quick Ratio 13.53
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -82.24% and return on invested capital (ROIC) is -55.62%.

Return on Equity (ROE) -82.24%
Return on Assets (ROA) -52.56%
Return on Invested Capital (ROIC) -55.62%
Return on Capital Employed (ROCE) -100.60%
Revenue Per Employee n/a
Profits Per Employee -$3.49M
Employee Count 51
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +20.73% in the last 52 weeks. The beta is -0.29, so MLYS's price volatility has been lower than the market average.

Beta (5Y) -0.29
52-Week Price Change +20.73%
50-Day Moving Average 13.35
200-Day Moving Average 12.35
Relative Strength Index (RSI) 63.61
Average Volume (20 Days) 826,408

Short Selling Information

The latest short interest is 6.09 million, so 9.39% of the outstanding shares have been sold short.

Short Interest 6.09M
Short Previous Month 4.71M
Short % of Shares Out 9.39%
Short % of Float 14.19%
Short Ratio (days to cover) 4.49

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -192.40M
Pretax Income -90.80M
Net Income -177.81M
EBITDA -192.36M
EBIT -192.40M
Earnings Per Share (EPS) -$3.66
Full Income Statement

Balance Sheet

The company has $198.19 million in cash and n/a in debt, giving a net cash position of $198.19 million or $3.05 per share.

Cash & Cash Equivalents 198.19M
Total Debt n/a
Net Cash 198.19M
Net Cash Per Share $3.05
Equity (Book Value) 191.26M
Book Value Per Share 3.84
Working Capital 190.71M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$166.31 million and capital expenditures -$96,000, giving a free cash flow of -$166.41 million.

Operating Cash Flow -166.31M
Capital Expenditures -96,000
Free Cash Flow -166.41M
FCF Per Share -$2.57
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MLYS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -34.13%
Shareholder Yield n/a
Earnings Yield -17.54%
FCF Yield -16.41%

Analyst Forecast

The average price target for MLYS is $33.00, which is 111.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target $33.00
Price Target Difference 111.07%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1